Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grudman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Genome Biology and Evolution|June 2, 2026
Conservation of Human IgSF Proteins Throughout Eukaryotic EvolutionSteven Grudman, Andras Fiser
Iscience|October 7, 2025
Overcoming research bias: The untapped potential of biomedically important but understudied proteinsSteven Grudman, Carlos Madrid-Aliste, Andras Fiser
Bioinformatics (Oxford, England)|August 21, 2023
Optimal selection of suitable templates in protein interface predictionSteven Grudman, J Eduardo Fajardo, Andras Fiser
Bioinformatics (Oxford, England)|September 9, 2021
INTERCAAT: identifying interface residues between macromoleculesSteven Grudman, J Eduardo Fajardo, Andras Fiser
Structure (London, England : 1993)|May 15, 2025
Structural insights from active site variants and β-8 loop interactions in viperin-like enzymesJake C Lachowicz, Steven Grudman, Jeffrey B Bonanno, et al.
Cancer Immunology Research|May 31, 2023
Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell MalignanciesBeatriz Aranda-Orgilles, Isabelle Chion-Sotinel, Jordan Skinner, et al.
Science Advances|August 30, 2024
Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancerPiril Erler, Tomasz Kurcon, Hana Cho, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Genome Biology and Evolution|June 2, 2026
Conservation of Human IgSF Proteins Throughout Eukaryotic EvolutionSteven Grudman, Andras Fiser
Iscience|October 7, 2025
Overcoming research bias: The untapped potential of biomedically important but understudied proteinsSteven Grudman, Carlos Madrid-Aliste, Andras Fiser
Bioinformatics (Oxford, England)|August 21, 2023
Optimal selection of suitable templates in protein interface predictionSteven Grudman, J Eduardo Fajardo, Andras Fiser
Bioinformatics (Oxford, England)|September 9, 2021
INTERCAAT: identifying interface residues between macromoleculesSteven Grudman, J Eduardo Fajardo, Andras Fiser
Structure (London, England : 1993)|May 15, 2025
Structural insights from active site variants and β-8 loop interactions in viperin-like enzymesJake C Lachowicz, Steven Grudman, Jeffrey B Bonanno, et al.
Cancer Immunology Research|May 31, 2023
Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell MalignanciesBeatriz Aranda-Orgilles, Isabelle Chion-Sotinel, Jordan Skinner, et al.
Science Advances|August 30, 2024
Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancerPiril Erler, Tomasz Kurcon, Hana Cho, et al.
Pageof 1